# Study of 4-Demethylcholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients With Advanced Cancer"

> **NCT01976910** · PHASE1 · COMPLETED · sponsor: **DEKK-TEC, Inc.** · enrollment: 23 (actual)

## Conditions studied

- Advanced Cancer

## Interventions

- **DRUG:** DM-CHOC-PEN

## Key facts

- **NCT ID:** NCT01976910
- **Lead sponsor:** DEKK-TEC, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2020-08-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01976910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01976910, "Study of 4-Demethylcholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients With Advanced Cancer"". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01976910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*